Zyrubin Lyophilized 50mg Injection
Marketer
Zydus Lifesciences Ltd
Salt Composition
Epirubicin (50mg)
Overview Zyrubin Lyophilized 50mg Injection
Lyophilized Zyrubin 50mg injection treats various hematologic, breast, gastric, pulmonary, ovarian, and soft tissue malignancies. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a qualified healthcare professional via infusion, it's used alone or in combination chemotherapy regimens. Dosage and frequency, determined by your physician, depend on your specific condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can have severe consequences. Benefits may not be apparent for weeks or months; discontinue only under medical supervision. Reliable contraception is crucial for both partners as this medication reduces contraceptive pill efficacy. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests monitor blood cell counts, kidney, liver, and cardiac function. Prior to treatment, disclose any liver or heart conditions, and list all other medications, as interactions can affect efficacy or drug action. Report pregnancy or breastfeeding to your doctor.
Uses of Zyrubin Lyophilized 50mg Injection
Malignant neoplasm
Major Benefits of Zyrubin Lyophilized 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Zyrubin Lyophilized 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Zyrubin Lyophilized 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zyrubin Lyophilized 50mg Injection works:
Zyrubin Lyophilized 50mg Injection is a breast cancer treatment that inhibits topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, damages cancerous DNA, halting cell proliferation and leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption with Zyrubin Lyophilized 50mg Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administration of Zyrubin Lyophilized 50mg Injection is contraindicated during pregnancy due to confirmed fetal risk. Exceptions may exist in life-threatening circumstances where the physician deems the potential benefits outweigh the inherent dangers. Physician consultation is advised.
Breast feedingUNSAFE
Administration of Zyrubin Lyophilized 50mg Injection is contraindicated during lactation. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Administration of Zyrubin Lyophilized 50mg Injection can induce adverse reactions that might compromise driving capabilities. Nausea and vomiting, potential side effects of Zyrubin Lyophilized 50mg Injection, may temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
The use of Zyrubin Lyophilized 50mg Injection in patients with kidney impairment appears to be generally safe. Existing evidence indicates dose modification may be unnecessary for these individuals, however, physician consultation is recommended. Reduced dosages might be warranted for patients exhibiting serum creatinine exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should receive Zyrubin Lyophilized 50mg Injection cautiously, potentially requiring dosage modification. Consult a physician before administration. Zyrubin Lyophilized 50mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Zyrubin Lyophilized 50mg Injection :
NA
Facts to Know About Zyrubin Lyophilized 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently